Globo Series News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Globo series. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Globo Series Today - Breaking & Trending Today

OBI Pharma Inc.: OBI Pharma Announces Discontinuation of the Phase 1/2 Study of its Antibody- OBI 888 to focus on other priority Cancer programs

TAIPEI, Taiwan, July 05, 2022 (GLOBE NEWSWIRE) OBI Pharma, a Taiwan biopharma company (TPEx: 4174), today announced discontinuation of the Phase 1/2 Study for OBI 888, a Globo H antibody, upon completion ....

T Ai Pei , Adagloxad Simolenin , Kostenloser Wertpapierhandel , Michael Chang , Kevin Poulos , Futures Bureau , Pharma Inc , Pharma United States Inc , Adagloxad Simolenin Vaccine , Globo Series , Private Securities Litigation Reform Act , Taiwan Securities , United States ,

OBI Pharma Announces Poster Presentations at the 2022 ASCO Annual Meeting for Adagloxad Simolenin, OBI-999, OBI-3424, and Exhibition Booth

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

T Ai Pei , United States , San Francisco , Adagloxad Simolenin , Kevin Poulos , Apostolia Maria Tsimberidou , Mccormick Center , American Society Of Clinical Oncology , University Of Texas Md Anderson Cancer Center , Futures Bureau , Pharma Inc , Pharma United States Inc , First In Class Cancer , American Society , Clinical Oncology , Antibody Drug Conjugate , Ming Tain Lai , Chief Scientific Officer , Globoh Positive , Breast Cancer , First In Human Study , Globoh Targeting Antibody Drug Conjugate , Advanced Solid , Developmental Therapeutics , Molecularly Targeted Agents , Apostolia Maria Tsimberidou Phd ,

OBI Pharma Inc.: OBI Pharma Announces Poster Presentations at the 2022 ASCO Annual Meeting for Adagloxad Simolenin, OBI-999, OBI-3424, and Exhibition Booth

Poster Presentations to highlight the ongoing clinical studies targeting Globo H and AKR1C3TAIPEI, Taiwan, May 17, 2022 (GLOBE NEWSWIRE) OBI Pharma, Inc. (TPEx: 4174), a leader in First-in-Class Cancer ....

T Ai Pei , United States , San Francisco , Adagloxad Simolenin , Kostenloser Wertpapierhandel , Kevin Poulos , Apostolia Maria Tsimberidou , Mccormick Center , American Society Of Clinical Oncology , University Of Texas Md Anderson Cancer Center , Futures Bureau , Pharma Inc , Pharma United States Inc , Poster Presentations , First In Class Cancer , American Society , Clinical Oncology , Antibody Drug Conjugate , Ming Tain Lai , Chief Scientific Officer , Globoh Positive , First In Human Study , Globoh Targeting Antibody Drug Conjugate , Advanced Solid , Apostolia Maria Tsimberidou Phd , Cancer Center ,

OBI Pharma, Inc.: OBI Pharma Announces Poster Presentations at AACR 2022 Annual Meeting for OBI-3424 and Globo H Science

Poster Presentations to highlight the latest research on OBI-3424 (AKR1C3 small molecule pro-drug) and emerging Globo H science. TAIPEI, Taiwan, April 7, 2022 /PRNewswire/ OBI Pharma ....

T Ai Pei , Chung Shan , T Ai Chung , United States , Zhanghua Xian , Adagloxad Simolenin , Chun Chung Wang , Lu Tzu Chen , Jhih Jie Yang , Kevin Poulos , Kostenloser Wertpapierhandel , Jiann Shiun Lai , Cheng Yen Wei , Chih Chan Lee , School Of Medicine , American Association Of Cancer Research , Pharma United States Inc , Obi Pharma Inc , Chung Shan Medical University , Futures Bureau , Department Of Pathology , Pharma Inc , Poster Presentations , American Association , Cancer Research , Annual Meeting ,

OBI Pharma Announces Poster Presentations at AACR 2022 Annual Meeting for OBI-3424 and Globo H Science

/PRNewswire/ OBI Pharma, Inc. (TPEx: 4174) today announced scientific data highlighting the antitumor synergy of OBI-3424 in combination with pembrolizumab. ....

T Ai Pei , Chung Shan , T Ai Chung , United States , Zhanghua Xian , Adagloxad Simolenin , Chun Chung Wang , Lu Tzu Chen , Jhih Jie Yang , Kevin Poulos , Jiann Shiun Lai , Cheng Yen Wei , Chih Chan Lee , School Of Medicine , American Association Of Cancer Research , Pharma United States Inc , Obi Pharma Inc , Chung Shan Medical University , Futures Bureau , Department Of Pathology , Pharma Inc , Poster Presentations , American Association , Cancer Research , Annual Meeting , New Orleans ,